Dr. Bryan Maguire:

We envisage it would be time limited. We do not yet have guidance in place in that regard but it would be sufficiently lengthy to enable the company to be able to justify the cost of investing in the actuarial predictions and so on and sufficiently limited so that there would not be an incumbent effect that would make it impossible to repeat procurement after a specified period. For services such as this, it strikes me a period of four or five years would be likely but we have not tested the market yet.